Provided by Tiger Trade Technology Pte. Ltd.

Sanofi SA

40.23
+0.03000.07%
Post-market: 40.360.1300+0.32%19:53 EDT
Volume:3.00M
Turnover:119.63M
Market Cap:96.39B
PE:21.58
High:40.27
Open:40.18
Low:39.58
Close:40.20
52wk High:52.68
52wk Low:39.18
Shares:2.40B
Float Shares:2.16B
Volume Ratio:0.75
T/O Rate:0.14%
Dividend:2.36
Dividend Rate:5.88%
EPS(TTM):1.86
EPS(LYR):3.76
ROE:5.71%
ROA:5.09%
PB:1.24
PE(LYR):10.70

Loading ...

Movement Alert|Sanofi Overnight Decline 3.15%, EU Launches Formal Antitrust Probe Over Flu Vaccine Disparagement Claims

Market Focus
·
Jun 30

Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO) and Sanofi (SNY)

TIPRANKS
·
Jun 29

Healthcare Stocks Have Become a Haven for Investors Ditching Tech

Dow Jones
·
Jun 27

Sanofi Under EU Scrutiny for Alleged Disparagement of Competing Influenza Vaccines

Stock News
·
Jun 26

Sanofi Faces EU Antitrust Probe Over Flu Vaccine Communication Campaign

MT Newswires Live
·
Jun 26

Dow Jones Top Company Headlines at 5 PM ET: Nike Names Pfizer's Denton as Next CFO | FedEx ...

Dow Jones
·
Jun 24

Sanofi Secures European Approval for Multiple Sclerosis Drug, Japan Clearance for Immune Disease Drug

MT Newswires Live
·
Jun 23

Sanofi and Abu Dhabi's Health Department Sign MoU to Explore Vaccine Innovation Centre

MT Newswires Live
·
Jun 23

Dow Jones Top Company Headlines at 3 AM ET: Oracle Sheds 21,000 Jobs | SpaceX, ...

Dow Jones
·
Jun 23

MacroGenics to Receive $24.5 Million in Regulatory Milestone Payment

MT Newswires Live
·
Jun 23

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
Jun 22

Movement Alert|Sanofi Falls 3.19% in Regular Trading, Phase III Trial Failure of Key Pipeline Drug Continues to Weigh on Shares

Market Focus
·
Jun 22

Sanofi Names New Pharma Research Head as CEO Moves to Speed Up Pipeline -- Update

Dow Jones
·
Jun 22

Movement Alert|Sanofi Falls 3.02% in Pre-Market Trading, Aftershocks From Core Pipeline Drug Phase III Trial Failure Continue

Market Focus
·
Jun 22

Movement Alert|Sanofi Falls 3.11% in Regular Trading, Continued Fallout from Core Pipeline Drug Phase III Trial Failure

Market Focus
·
Jun 18

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

MT Newswires Live
·
Jun 17

European Equities Traded in the US as American Depositary Receipts Surge in Monday Trading

MT Newswires Live
·
Jun 15

Sanofi Says US FDA Approved Tzield for Recently Diagnosed Stage 3 Type 1 Diabetes in Children

MT Newswires Live
·
Jun 15

Sanofi's Tzield Receives FDA Approval for Diabetes Treatment

Dow Jones
·
Jun 13

Buy Dianthus on weakness amid ‘overdone’ selloff, says H.C. Wainwright

TIPRANKS
·
Jun 10